Our Cannabis Attorney Services
Lawyers in Womble Bond Dickinson’s Cannabis practice are working closely with cannabis companies and other market participants to grow their business, protect their innovations, fulfill their regulatory and compliance responsibilities, and legally defend their products and services.
For nearly half a century, Womble Bond Dickinson has represented high-profile companies in highly regulated industries, including dietary supplements, food, beverages, homeopathic medicines, prescription pharmaceuticals for both human and veterinary uses, medical devices, cosmetics, personal care products, tobacco, e-cigarettes, healthcare, life sciences and wellness, among others. Whether in the courtroom, the board room, or before the Food and Drug Administration (FDA), we bring years of hands-on experience to bear for our cannabis clients.
Our multi-disciplinary Cannabis Team provides the full spectrum of legal services often required by companies operating in this fast-changing industry as well as in the vast network of ancillary products and services. Our attorneys, jurisdiction permitting, serve businesses at every level of the cannabis supply chain. We have extensive experience advising clients on the federal and state laws and regulations relevant to the industry, including the Controlled Substances Act, Agriculture Improvement Act of 2018 (Farm Bill), the Food, Drug, and Cosmetic Act (FDCA), relevant rules, regulations, and guidance from the U.S. Department of Justice (DOJ), the U.S. Drug Enforcement Agency (DEA), the U.S. Food and Drug Administration (FDA), U.S. Department of Agriculture and state-specific marijuana, CBD and hemp law and regulations.
We can scale our services and customize teams based on the life cycle of your business – bringing in the right resources when you need them.
Our core services include:
Our corporate and transactional lawyers can help you structure and finance your growing business. We represent clients in a full-range of complex transactions, including mergers and acquisitions, reorganizations and divestitures, corporate financing, equipment leasing and finance, strategic alliances and joint ventures. We also advise on corporate governance and regulatory matters, including counseling company executives and boards of directors on their fiduciary duties under state law.
Innovation is the lifeblood of your company. We work alongside you when new products and services are developed, produced, and introduced to the market, and we help protect and defend your valuable intellectual property assets including patents, trademarks, copyrights and trade secrets. We also advise on marketing and advertising compliance that accompany new product development.
Our team of regulatory professionals and Ph.D. level scientists has the in-depth knowledge and experience interacting with the FDA to guide you in navigating the complex regulatory landscape. We assist new product developers, established manufacturers, and retailers with their regulatory needs. We have a full range of regulatory services, including strategic and technical guidance, regulatory submissions, preclinical testing, GMP manufacturing support, and FDA inspection preparation. Our regulatory lawyers can also help you respond to (and proactively seek to avoid) FDA warning letters, internal investigations, and enforcement actions.
When litigation is necessary, our trial-tested litigators defend companies in complex commercial, intellectual property, and product liability litigation throughout the United States. Our WBD Advance services, such as the Case Management Facility, BullDox eDiscovery and Information Management, Medical and Scientific Solutions, and Graphic Solutions, are designed to help companies control costs and improve outcomes in high-stakes, complex litigation. Our team also regularly represents companies in resolving disputes through arbitration and mediation.
No legal advice that our firm gives is intended to provide any guidance or assistance in violating federal or state laws. Please note that possessing, using, distributing, and selling marijuana are crimes under federal and some state laws. All firm services are subject to the firm’s obligations under applicable state and federal law and rules of professional conduct.
Seed to Sale Series
Our Seed to Sale webinar series has ended, but you can still view past webinars on demand by clicking the links below:
- Growing the Intellectual Property Portfolio for Your Canna-biz
- The Buzz on Understanding the FDA Regulatory Landscape for Cannabis
- Keeping Out of the Weeds in Corporate and Financial Transactions
- Practical Guidance on Hashing Out the Patchwork of State and Federal Laws
Click the links below to read articles adapted from the webinars:
- Seed to Sale: Practical Guidance on Hashing Out the Patchwork of State and Federal Laws
- Seed to Sale: IP Considerations in the Cannabis Landscape
- Seed to Sale: The Buzz on Understanding the FDA Regulatory Landscape for Cannabis
- Seed to Sale: Keeping Out of the Weeds in Corporate and Financial Transactions